Last updated: 22 July 2019 at 3:22am EST

Christine R Larson Net Worth




The estimated Net Worth of Christine R Larson is at least 158 百万$ dollars as of 14 May 2010. Christine Larson owns over 5,000 units of PDL Biopharma Inc stock worth over 157,758,894$ and over the last 16 years Christine sold PDLI stock worth over 0$.

Christine Larson PDLI stock SEC Form 4 insiders trading

Christine has made over 2 trades of the PDL Biopharma Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Christine bought 5,000 units of PDLI stock worth 28,550$ on 14 May 2010.

The largest trade Christine's ever made was buying 10,000 units of PDL Biopharma Inc stock on 30 April 2010 worth over 61,800$. On average, Christine trades about 3,000 units every 3 days since 2009. As of 14 May 2010 Christine still owns at least 43,749 units of PDL Biopharma Inc stock.

You can see the complete history of Christine Larson stock trades at the bottom of the page.



What's Christine Larson's mailing address?

Christine's mailing address filed with the SEC is C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BLVD, INCLINE VILLAGE, NV, 89451.

Insiders trading at PDL Biopharma Inc

Over the last 22 years, insiders at PDL Biopharma Inc have traded over 45,966,964$ worth of PDL Biopharma Inc stock and bought 12,693,393 units worth 32,804,545$ . The most active insiders traders include Point Capital L.P.O'shea Ro...Faheem HasnainLaurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of 245,074,578$. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth 383,475$.



What does PDL Biopharma Inc do?



Complete history of Christine Larson stock trades at Dynavax Technologies、PDL Biopharma Inc

インサイダー
取引
取引
合計金額
Christine R Larson
副総裁、最高財務責任者
購入する 28,550$
14 May 2010
Christine R Larson
副総裁、最高財務責任者
購入する 61,800$
30 Apr 2010


PDL Biopharma Inc executives and stock owners

PDL Biopharma Inc executives and other stock owners filed with the SEC include: